 |
Immunovaccine : Home
IMV, IVT, ImmunoVaccine Technologies Inc, ImmunoVaccine Technologies, Randall Chase, Randal Chase, Dr. Randal Chase, vaccine, cancer vaccine, influenza vaccine, Immunovaccine, Immunovaccine Technologies, pseudomonas, pseudomonas vaccines, infectious disease, Dalhousie, Dalhousie University, immunology, immunologist, biotech research, vaccine delivery system, therapeutic cancer, therapeutic cancer vaccine, infectious diseases, DepoVax™, Depovax, DepoVax, DepoVax™ Platform,DepoVax™ Challenge, H5N1, Pandemic influenza, Hepatitus B vaccine, Whooping cough, Pfizer Animal Health, Pfizer, licensed our, R&D for vaccine, LaJolla Institute, LaJolla, National Institute of Health, Defence Research & Development Canada, FIT Biotech, Scancell Ltd., National Cancer Institute, Peptides, Proteins, DNA, RNA, SiRNA, patent, peptide anitgen, peptide antigens, clinic, IND, FDA, safety, tolerability,Pseudomonas, pseudomonas aeruginosa, pseudomonas aeurginosa vaccine, Pseudomonas antigens, Yokohoma City University, Brian Lowe, Brian E. Lowe, Marc Mansour, Mark Mansour, Dr. Marc Mansour, Dr. Mark Mansour, Ella Korets-Smith, Dr. William Cochrane, Dr. Bill Cochrane, Dr. Cochrane, William Cochrane, Bill Cochrane, W. Martin Kast, Dr. Kastr, Neil Berinstein, Dr. Neil Berinstein, Michel Klein, Waleter Storkus, Irene Clement, Immunovaccine financing, Phase I clinical trial, Phase 1 clinical trial, Top 10 Life Sciences Companies, IND (Investigational New Drug), Cato Research, ACOA, Atlantic Innovation Fund (AIF), NRC Industrial Research Assistance Program (NRC-IRAP) ovarian cancer, breast cancer, prostate cancer, better vaccines, cancer and infectious disease
Imvaccine.com ~
Site Info
Whois
Trace Route
RBL Check
|
Site Info
